Appropriate Candidates for Hemiablative Focal Therapy Are Infrequently Encountered Among Men Selected for Radical Prostatectomy in Contemporary Cohort

Urology

Volumn 73, Issue 2, 2009, Pages 351-354

  Tareen, Basir ^a   Sankin, Alex ^a   Godoy, Guilherme ^a   Temkin, Steve ^a   Lepor, Herbert ^a   Taneja, Samir S ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER THERAPY; CLINICAL FEATURE; GLEASON SCORE; HEMIABLATIVE FOCAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ORGAN SIZE; PATIENT SELECTION; PREVALENCE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATECTOMY; SEMINAL VESICLE; SURGEON; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; AGED; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 58649102673     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.08.504     Document Type: Article

References (21)

1. Catalona W.J., and Basler J.W. Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. J Urol 150 (1993) 905-907
2. Walsh P.C., and Donker P.J. Impotence following radical prostatectomy: insight into etiology and prevention 1982. J Urol 167 (2002) 1005-1010
3. Talcott J.A., Rieker P., Propert K.J., et al. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst 89 (1997) 1117-1123
4. Harlan S.R., Cooperberg M.R., Elkin E.P., et al. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE. J Urol 170 (2003) 1804-1807
5. Eggener S.E., Scardino P.T., Carroll P.R., et al. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol 178 (2007) 2260-2267
6. Onik G., Vaughan D., Lotenfoe R., et al. "Male lumpectomy": focal therapy for prostate cancer using cryoablation. Urology 70 (2007) 16-21
7. Jones J.S. Focal or subtotal therapy for early stage prostate cancer. Curr Treat Options Oncol 8 (2007) 165-172
8. Onik G., Narayan P., Vaughan D., et al. Focal "nerve-sparing" cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology 60 (2002) 109-114
9. Lambert E.H., Bolte K., Masson P., et al. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Urology 69 (2007) 1117-1120
10. Bahn D.K., Silverman P., Lee Sr. F., et al. Focal prostate cryoablation: initial results show cancer control and potency preservation. J Endourol 20 (2006) 688-692
11. Bahn D.K., Lee F., Badalament R., et al. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 60 (2002) 3-11
12. Mouraviev V., Mayes J.M., Sun L., et al. Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer. Cancer 110 (2007) 906-910
13. Wise A.M., Stamey T.A., McNeal J.E., et al. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology 60 (2002) 264-269
14. Stamey T.A., McNeal J.E., Freiha F.S., et al. Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 139 (1988) 1235-1241
15. Bostwick D.G., Graham Jr. S.D., Napalkov P., et al. Staging of early prostate cancer: a proposed tumor volume-based prognostic index. Urology 41 (1993) 403-411
16. Villamon-Fort R., Martinez-Jabaloyas J.M., Soriano-Sarria P., et al. Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy. Urol Int 78 (2007) 328-333
17. Master V.A., Chi T., Simko J.P., et al. The independent impact of extended pattern biopsy on prostate cancer stage migration. J Urol 174 (2005) 1789-1793
18. Sofer M., Savoie M., Kim S.S., et al. Biochemical and pathological predictors of the recurrence of prostatic adenocarcinoma with seminal vesicle invasion. J Urol 169 (2003) 153-156
19. Pelzer A.E., Colleselli D., Bektic J., et al. Pathological features of Gleason score 6 prostate cancers in the low and intermediate range of prostate-specific antigen level: is there a difference?. BJU Int 101 (2008) 822-825
20. Epstein J.I., Carmichael M.J., Partin A.W., et al. Small high grade adenocarcinoma of the prostate in radical prostatectomy specimens performed for nonpalpable disease: pathogenetic and clinical implications. J Urol 151 (1994) 1587-1592
21. Cheng L., Jones T.D., Pan C.X., et al. Anatomic distribution and pathologic characterization of small-volume prostate cancer (<0.5 ml) in whole-mount prostatectomy specimens. Mod Pathol 18 (2005) 1022-1026